Unusual phosphine oxidation: new triazolopyridyl-quinolyl phosphine oxide fluorescent dyes

R. Ballesteros-Garridoab, B. Abarca*b, R. Ballesteros*b, F. Colobert*a, F. R. Leroux*a and E. García-España*c
aLaboratoire de Chimie Moléculaire, UMR CNRS 7509, Université de Strasbourg (ECPM), 25 rue Becquerel, 67087 Strasbourg, France
bDepartamento de Química Orgánica, Facultad de Farmacia, Universidad de Valencia, Avd. Vte. Andrés Estellés s/n, 46100 Burjassot, Valencia, Spain. E-mail: rafael.ballesteros@uv.es
cICMol Instituto de Ciencia Molecular, Universidad de Valencia, C. Catedrático José Beltrán 2, Paterna, Valencia, Spain

Received 21st January 2015 , Accepted 16th March 2015

First published on 17th March 2015


Abstract

3-(2-Pyridyl)-[1,2,3]triazolo[1,5-a]quinolylphosphines suffer an unusual phosphine oxidation due to their special geometry that allows a σ-donation of the nitrogen (N1) lone pair to phosphorus. This family of compounds behaves as strong fluorophores with high quantum yields.


The chemistry of [1,2,3]triazolo[1,5-a]pyridines 1 or [1,2,3]triazolo [1,5-a]quinolines 2 has been reported as a powerful tool in synthetic chemistry (Fig. 1).1–5 Position 7 in triazolopyridine 1 and 9 in triazoloquinoline 2 can be easily functionalized by means of regioselective lithiation and subsequent trapping with an electrophile.
image file: c5ra04386g-f1.tif
Fig. 1 Triazolopyridine 1 and triazoloquinoline 2.

These systems are in equilibrium with a diazo compound (see Scheme 1).6,7 When substituted at position C3 with a pyridyl ring (R = 2-pyridyl), the intermediate diazo compound can undergo cyclization to the five membered ring system via two possible nitrogen atoms giving the equilibria 13 or 24, respectively (Scheme 1). This equilibrium, known as ring-chain isomerization, is controlled by the different substituents (X), either by electronic effects in compound 1,6 or electronic and steric effects in compound 2.7


image file: c5ra04386g-s1.tif
Scheme 1 Ring-chain isomerization in 1 and 2.

In the framework of our work on triazolopyridines and quinolines we have studied several applications based on this particular and intriguing ring-chain isomerization including the preparation of fluorescent dyes,8 tridentate ligands,9 and phosphines based on scaffold 1 (X = PPh2, PCy2, PiPr2…) as efficient sensors for the electronic profile of phosphines.10 Furthermore, heterocyclic phosphines represent an unique and efficient family of ligands for homogeneous transition metal-mediated catalysis.11

Following these studies, we become interested in the preparation of phosphine derivatives based on the triazoloquinoline scaffold 2 in order to evaluate the influence of steric and electronic properties of phosphorus in the ring-chain equilibrium. Scheme 2 illustrates our approach towards the phosphine derivative. Regioselective lithiation of 2 gives intermediate 5 which upon treatment with ClPPh2 should afford phosphine 6. However, according to our previous studies,7 bulky substituents, like a PPh2-group, should isomerize to a tridentate structure 7 via the ring-chain isomerization.


image file: c5ra04386g-s2.tif
Scheme 2 Scheduled preparation of 7 by means of ring chain isomerization.

However, when performing the reaction, compound 7 was never observed. In contrast, the corresponding fluorescent phosphine oxide 8 has been obtained in an excellent 89% yield (Scheme 3). Then we prepared a large family of trizolopyridine derivatives bearing different phosphines (i.e. 1 with X = P(Ar, Alk)2). In no case a similar sensitivity towards oxidation has been observed.10,12 It is well known that aromatic tertiary phosphines are air stable, and those bearing deficient heteroaromatic rings (like in the case of trizaoloquinoline) should be even more stable towards oxidation.13


image file: c5ra04386g-s3.tif
Scheme 3 Obtention of compound 8.

Next, due to this uncommon behavior the electronic nature of the ClPAr2 reagent has been modified. When the electron-deficient (p-CF3-Ph)2PCl has been used phosphine oxide 9 was once again obtained in high yield (81%). We were able to obtain suitable single crystals and perform X-ray diffraction studies which confirmed the presence of a phosphine oxide on a tridentate structure (Scheme 4).


image file: c5ra04386g-s4.tif
Scheme 4 Preparation of compounds 9, 10 and 11. ORTEP view of compound 9. R = p-CF3-Ph, R′ = p-H3CO-Ph.

Employing similar conditions, now with more electron-rich phosphines, the corresponding phosphine oxide were isolated in moderate yields. With a para-methoxyphenyl group, compound 10 has been obtained in 72% yield, and with cyclohexyl phosphine compound 11 in 59% (Scheme 4). The NMR spectra of the ring-chain isomerized compounds 8–11 show the characteristic coupling constants for H7 (J = 7 Hz) and H4 (J = 9 Hz) of triazolopyridines (Fig. 2).6a,7


image file: c5ra04386g-f2.tif
Fig. 2 1H-NMR spectra (aromatic domain) of 8, 9, 10 and 11 (from top to bottom).

31P-NMR also indicates the presence of a phosphine oxide for all derivatives (31P NMR: 8: δ = 31.9 ppm, 9: δ = 28.0 ppm, 10: δ = 30.6 ppm and 11: δ = 48.1). These values are within the range of phosphine oxides. Noteworthy, the oxidation of arylphosphines require in general oxidants and normally it does not take place under atmospheric conditions. Wang et al. reported the oxidation of phosphine 12 employing excess H2O2 as oxidant leading to 13 in 72% yield (Scheme 5).14 The structure of compound 12 ressembles the non-oxidized triazoloquinoline derivatives (7). However, in our case air (introduced during the work up) induced rapid oxidation of the formed phosphines.


image file: c5ra04386g-s5.tif
Scheme 5 Wang methodology for the oxidation of compound 12.

To explain why the spontaneous oxidation in the case of 3-(2-pyridyl)-9-triazoloquinolylphosphines occurs, we suppose that isomers 6 have a particular geometry in which a preferential conformation with σ-donation of the nitrogen (N1) lone pair towards phosphorus becomes possible. This leads to an increased electron-density at phosphorus and makes it more susceptible for oxidation towards oxide 14. Next, ring-chain isomerization to structure 8 happens (Scheme 6).


image file: c5ra04386g-s6.tif
Scheme 6 Proposed mechanism for the formation of 8.

This feature has been employed by Verkade,15 for the preparation of extremely basic (electron-rich phosphorus) compounds presenting high sensitivity towards molecular oxygen in contrast to air stable triphenylphosphine.

Heterocyclic P–N ligands and their corresponding oxides have significant applications in catalysis and as chemosensors.14 Therefore, we studied the fluorescence properties of these novel compounds. In the past we have reported on triazolopyridine and triazoloquinoline derivatives as excellent chemosensors but moderate quantum yields.7–9 However, any of our previous triazolopyridyl phosphine derivatives gave significant emission.10 The corresponding measured emission properties of compounds 8–11 are reported in Table 1. Surprisingly, all of them exhibited intense emission upon irradiation at its higher absorption band.

Table 1 λexc and λem in nm
Entry Compound λexc (nm) λem (nm) Quantum yielda φF
a Quantum yield: ratio of the number of emitted photons to the number of absorbed photons. Solutions were prepared 5 × 10−5 M in ethanol. Quantum yield was determined with a Hamamatsu-PHA equipment.
1 1 359 411 0.01
2 2 358 397 0.13
3 8 376 423 0.54
4 9 380 427 0.60
5 10 375 419 0.48
6 11 369 404 0.34


Compounds 8–10 have high quantum yields (Table 1 entry 3, 4 and 5) when compared with parent compounds 1 or 2. Another tendency is that electron-donating substituents on the aromatic phosphine substituent induce a hypsochromic shift of 4 nm (comparing 8: 423 nm with 10: 419 nm), and more electron-rich systems like 11 present a higher shift (19 nm for 11). The electron-withdrawing trifluormethyl group in 9 induces a more significant opposed effect (bathochromic shift) of 4 nm. In Fig. 3, the emission spectra are presented as well as a picture of the emission of compounds 11 (left) and 10 (right).


image file: c5ra04386g-f3.tif
Fig. 3 Normalized maximum emission spectra for compounds 8 (black), 9 (green), 10 (red) and 11 (violet). Inset compounds 11 and 10 (10−5 M in ethanol).

In order to analyse the viability as sensors for metals we first studied the luminescent behaviour of the compounds in presence of Zn(II) and Cu(II).9 While no changes were observed for Zn(II), Cu(II) induced a quenching of the fluorescence (Fig. 4) of all compounds.16 Among them, 10 and 11 have the highest binding constants (Table 2) experimenting a complete quenching upon the addition of two equivalents of copper solution.


image file: c5ra04386g-f4.tif
Fig. 4 Normalized maximum emission quenching spectra upon the addition of Cu2+ (0.004945 M in water) for compounds 8 (black), 9 (green), 10 (red) and 11 (violet) 5 × 10−5 M in ethanol.
Table 2 Binding constants17 with coppera
  8 9 10 11
a Solutions of compounds 8–11 were prepared 5 × 10−5 M in ethanol (2 mL sample), [Cu2+] 0.00494 M in water. Values in parenthesis are standard deviations in the last significant figure.
log[thin space (1/6-em)]K 4.05(1) 4.56(8) 4.836(8) 5.016(8)


Moreover, a more exhaustive study was performed with 11 to find out if the fluorescence response was selective for copper.18 Fig. 5 shows the normalized emission intensities after the addition of Zn(II), Co(II), Ni(II), Cu(II), Mn(II), Pb(II), Cd(II), Ag(I), Fe(II)and Fe(III) solutions to an ethanolic solution of 11. Complete fluorescence quenching is exclusively observed with Cu(II) (blue columns); addition of 3 equivalents of the other metal ions tested (black columns in Fig. 5) does not produce any change. However, it is important to remark that in almost all cases the presence of 3 eq. of the other metal ions does not disturb the quenching when copper(II) is subsequently added (red columns). Only Fe(II) and Fe(III) do present interference. Finally, the addition of aqueous ammonia to solutions of 11 with 3 equivalents of Cu(II) avoids the quenching (by copper ammonia complexation, green column) see Fig. S14–S24 for full spectra.


image file: c5ra04386g-f5.tif
Fig. 5 Normalized emission quenching spectra (404 nm) of ligand 11 (5 × 10−5 M in ethanol) upon the addition of different metals (black lines) for compound 11 (3 mL 2.98 10−5 M, grey). Copper tests are reported in blue, mixed (3 eq. of Mn+ + 3 eq. of Cu(II)) are reported in red, and ammonia ligand displacement in green.

Conclusions

We have reported on a spontaneous oxidation of pyridyltriazoloquinolyl phosphines affording strong fluorophores able to sense copper with high binding constants. This oxidation can be rationalized by means of a hypervalent phosphorus atom that can be present due a particular conformational arrangement which increases the electron density at phosphorus. The electron enriched phosphorus atom becomes highly air sensitive and oxidyzes spontaneously. Next, a ring-chain isomerization provides the fluorescent compounds. These compounds have been shown as good copper sensors. Compound 11 has been studied more in detail and has shown high selectivity for copper even in presence of other transition metals.

Experimental

3-(Pyridin-2-yl)-[1,2,3]triazolo[1,5-a]quinolone 2 was synthesized as described7

General procedure for the preparation of compounds 8–11. At −78 °C, butyllithium (1.6 mL, 2.2 mmol, 1.1 eq.) in hexanes (1.5 M) was added dropwise to a solution of 3-(pyridin-2-yl)-[1,2,3]triazolo[1,5-a]quinoline 2 (0.5 g, 2.0 mmol, 1.0 eq.) in tetrahydrofuran (50 mL). The mixture was kept for 30 min at −78 °C before a solution of the corresponding Ar2PCl (2.3 mmol, 1.2 eq.) in tetrahydrofuran (1 mL) was added and allowed to reach 25 °C (1 h). Then a saturated aqueous solution of ammonium chloride (20 mL) was added. The resulting mixture was extracted with dichloromethane (3 × 10 mL). The organic extracts were combined, washed with brine (10 mL), dried over sodium sulphate, filtered, and concentrated. Sonication with ethyl acetate (40 mL, 1 minute) provided the phosphine oxides 8–11.
2-([1,2,3]Triazolo[1,5-a]pyridin-3-yl)-8-(diphenylphosphoryl)-quinoline 8. Yellow powder (0.8 g, 89%). mp 241 °C decomp. 1H NMR (300 MHz, CDCl3): δ = 9.06 (d, J = 8.9 Hz, 1H), 8.68 (d, J = 6.9 Hz, 1H), 8.57 (d, J = 8.7 Hz, 1H), 8.29 (dd, J = 8.7, 1.1 Hz, 1H), 8.03 (d, J = 7.9 Hz, 1H), 7.8–7.7 (m, 4H), 7.6–7.3 (m, 9H), 7.02 (ddd, J = 6.8, 6.8, 0.7 Hz, 1H). 13C NMR (75.5 MHz, CDCl3): δ = 152.1 (C), 148.8 (d, J = 4.4 Hz, C), 137.3 (d, J = 10.5 Hz, CH), 137.0 (d, J = 21.0 Hz, C), 136.9 (CH), 133.9 (C) 133.0 (d, J = 2.7 Hz, CH), 132.7 (d, J = 20.6 Hz, 2C), 132.0 (d, J = 9.9 Hz, 4CH), 131.5 (d, J = 2.9 Hz, 2CH), 130.8 (d, J = 1.4 Hz, C) 128.4 (d, J = 12.3 Hz, 4CH), 127.7 (d, J = 7.1 Hz, C), 127.1 (CH), 125.0 (d, J = 13.7 Hz, CH), 124.7 (CH), 122.6 (CH), 119.9 (CH), 116.3 (CH). 31P NMR (161 MHz, CDCl3): δ = 31.0 (PO). MS (EI): m/z (%) = 446(10), 418(52), 417(100), 340(19). HRMS ESI-[TOF] for C27H19N4OP: calcd. 446.1296; found 446.1300.
2-([1,2,3]Triazolo[1,5-a]pyridin-3-yl)-8-(bis(4-trifluoromethylphenyl)phosphoryl)quinoline 9. Yellow powder (0.5 g, 81%). mp 247–250 °C decomp. 1H NMR (300 MHz, CDCl3): δ = 8.75 (d, J = 8.9 Hz, 1H), 8.64 (d, J = 7.0 Hz, 1H), 8.53 (d, J = 8.7 Hz, 1H), 8.25 (dd, J = 8.7, 1.5 Hz, 1H), 8.03 (d, J = 7.9 Hz, 1H), 7.83 (d, J = 11.7 Hz, 2H), 7.80 (d, J = 11.8 Hz, 2H), 7.62–7.54 (m, 4H), 7.55–7.41 (m, 2H), 7.27 (dd, J = 8.9, 6.8 Hz, 1H), 6.97 (dt, J = 6.8, 6.8, 1.1 Hz, 1H). 13C NMR (75.5 MHz, CDCl3): δ = 152.6 (C), 148.7 (d, J = 4.46 Hz, C), 137.9 (C), 137.3 (d, J = 10.5 Hz, CH), 137.0 (d, J = 1.0 Hz, CH), 136.9 (d, J = 30.0 Hz, C), 136.5 (C), 133.93 (CH), 133.9 (CH), 133.7 (qd, J = 30.4, 30.4, 30.4, 1.1 Hz, 2 × C), 132.7 (C), 132.4 (d, J = 10.2 Hz, 4 × CH), 127.7 (d, J = 7.4 Hz, 2 × C), 127.6 (C), 127.3 (CH), 127.4 (q, J = 280.1 Hz, 2 × C), 125.4 (dq, J = 11.1, 3.7, 3.7, 3.7 Hz, 4 × CH), 125.1 (CH), 121.7 (CH), 120.5 (CH), 116.4 (CH). 31P NMR (161 MHz, CDCl3): δ = 28.0 (PO). MS (EI): m/z (%) = 582(12), 555(43), 554(100), 553(80), 533(47), 409(33), 355(50), 338(38). HRMS ESI-[TOF] for C29H17F6N4OP: calcd. 582.1044; found 582.1048.
2-([1,2,3]Triazolo[1,5-a]pyridin-3-yl)-8-(bis(4-methoxyphenyl)phosphoryl)quinoline 10. Pale colourless needles (0.4 g, 72%). mp 260 °C decomp. 1H NMR (300 MHz, CDCl3): δ = 9.11 (d, J = 8.9 Hz, 1H), 8.67 (d, J = 7.0 Hz, 1H), 8.54 (d, J = 8.7 Hz, 1H), 8.25 (dd, J = 8.7, 1.2 Hz, 1H), 7.99 (d, J = 8.0 Hz, 1H), 7.69–7.58 (m, 4H), 7.59–7.49 (m, 1H), 7.43 (dt, J = 7.7, 7.4, 2.3 Hz, 1H), 7.35 (dd, J = 8.3, 7.2 Hz, 1H), 7.00 (t, J = 6.8, 6.8 Hz, 1H), 6.86 (dd, J = 8.8, 2.0 Hz, 4H), 3.75 (s, 6H). 13C NMR (75.5 MHz, CDCl3): δ = 162.0 (d, J = 2.8 Hz, 2 × C), 152.1 (C), 150.0 (d, J = 4.4 Hz. C), 137.4 (C), 137.2 (d, J = 10.5 Hz, CH), 136.7 (CH), 133.8 (d, J = 11.3 Hz, 4 × CH), 132.8 (d, J = 2.6 Hz, CH), 131.8 (C), 130.4 (C), 127.6 (d, J = 7.0 Hz, 2 × C), 127.1 (CH), 125.7 (C), 125.0 (d, J = 13.7 Hz, CH), 124.7 (CH), 124.2 (C), 122.8 (CH), 119.7 (CH), 116.4 (CH), 113.9 (d, J = 13.4 Hz, 4 × C), 55.2 (s, 2C). 31P NMR (161 MHz, CDCl3): δ = 30.6 (PO). MS (EI): m/z (%) = 506(12), 478(37), 477(100), 462(22). HRMS ESI-[TOF] for C29H23N4O3P: calcd. 506.1508; found 506.1504.
2-([1,2,3]Triazolo[1,5-a]pyridin-3-yl)-8-(dicyclohexylphosphoryl) quinoline 11. Pale yellow needles (0.3 g, 59%). mp 235 °C decomp. 1H NMR (300 MHz, CDCl3): δ = 8.88 (app d, J = 7.2 Hz, 2H), 8.68 (d, J = 8.5 Hz, 1H), 8.46 (dd, J = 11.8, 6.8 Hz, 1H), 8.32 (d, J = 8.6 Hz, 1H), 7.99 (d, J = 7.9 Hz, 1H), 7.65 (t, J = 7.4, 7.4 Hz, 1H), 7.51 (dd, J = 8.6, 7.0 Hz, 1H), 7.17 (t, J = 6.8, 6.8 Hz, 1H), 2.9–2.7 (m, 2H), 2.4–2.2 (m, 2H), 1.9–0.8 (m, 18H). 13C NMR (75.5 MHz, CDCl3): δ = 151.7 (C), 147.6 (C), 137.9 7 (d, J = 5.6 Hz, CH), 137.7 (d, J = 2.2 Hz, CH), 137.6 (d, J = 20.1 Hz, C), 137.5 (C), 131.9 (d, J = 1.5 Hz, CH), 131.8 (C), 127.3 (d, J = 7.2 Hz, C), 126.8 (d, J = 0.8 Hz, CH), 125.9 (CH), 125.7 (d, J = 10.2 Hz, CH), 119.9 (CH), 119.9 (CH), 116.1 (CH), 38.2 (d, J = 67.1 Hz, 2 × CH), 26.7 (d, J = 3.5 Hz, 2 × CH2), 26.6 (2 × CH2), 26.0 (d, J = 3.6 Hz, 2 × CH2), 25.7 (4 × CH2). 31P NMR (161 MHz, CDCl3): δ = 48.1 (PO). MS (EI): m/z (%) = 458(39), 430(47), 376(31), 348(30), 347(30), 301(22), 267(100) 266(30), 265(45), 219(36), 218(29). HRMS ESI-[TOF] for C29H31N4OP: calcd. 458.2235; found 458.2229.

Acknowledgements

This work was financially supported by the CNRS (Centre National de la Recherche Scientific), France. We are also grateful to the Ministerio de Ciencia e Innovación (Spain) (Project CONSOLIDER-INGENIO SUPRAMED CSD 2010-00065), to Generalitat Valenciana (Valencia, Spain) (project PROMETEO 2011/008) for its financial support. R. B.-G. is much indebted to the “Ministère de l'Education Nationale et de la Recherche” for a doctoral fellowship. We are indebted to Dr Lydia Brelot (Service de Radiocristallographie, University of Strasbourg, France) for her assistance with the single crystal structure elucidation and SCIES (University of Valencia) for the HRMS. We would like to thank referees for their suggestions.

References

  1. B. Abarca and R. Ballesteros-Garrido, Topics in Heterocyclic Chemistry, Chemistry of 1,2,3-triazoles, Springer, Heildelberg, 2014, vol. 40, pp. 325–378 Search PubMed.
  2. G. Jones and B. Abarca, Adv. Heterocyclic Chem., The chemistry of the [1,2,3]triazolo[1,5-a]pyridines: an update, Elsevier, Heildelberg, 2010, vol. 100, pp. 195–252 Search PubMed.
  3. Y. Shi, A. V. Gulevich and V. Gevorgyan, Angew. Chem., Int. Ed., 2014, 53, 14191–14195 CrossRef CAS PubMed and references therein cited.
  4. R. Ballesteros-Garrido, F. R. Leroux, R. Ballesteros, B. Abarca and F. Colobert, Tetrahedron, 2009, 65, 4410–4417 CrossRef CAS PubMed.
  5. G. Jones and D. R. Sliskovic, J. Chem. Soc., Perkin Trans. 1, 1982, 967–971 RSC.
  6. (a) F. Blanco, I. Alkorta, J. Elguero, V. Cruz, B. Abarca and R. Ballesteros, Tetrahedron, 2008, 64, 11150–11158 CrossRef CAS PubMed; (b) B. Abarca, I. Alkorta, R. Ballesteros, F. Blanco, M. Chadlaoui, J. Elguero and F. Mojarrad, Org. Biomol. Chem., 2005, 3, 3905–3910 RSC and references therein cited.
  7. R. Ballesteros-Garrido, F. Blanco, R. Ballesteros, F. R. Leroux, B. Abarca, F. Colobert, I. Alkorta and J. Elguero, Eur. J. Org. Chem., 2009, 5765–5778 CrossRef CAS.
  8. R. Ballesteros-Garrido, E. Delgado-Pinar, B. Abarca, R. Ballesteros, F. R. Leroux, F. Colobert, R. J. Zaragoza and E. Garcia-España, Tetrahedron, 2012, 68, 3701–3707 CrossRef CAS PubMed.
  9. R. Ballesteros-Garrido, B. Abarca, R. Ballesteros, C. Ramirez de Arellano, F. R. Leroux, F. Colobert and E. Garcia-Espana, New J. Chem., 2009, 33, 2102–2106 RSC.
  10. R. Ballesteros-Garrido, L. Bonnafoux, F. R. Leroux, B. Abarca and F. Colobert, Dalton Trans., 2009, 5068–5070 RSC.
  11. S. M. Wong, C. M. So and F. Y. Kwong, Synlett, 2012, 1132–1153 CAS and references cited therein.
  12. R. Ballesteros-Garrido, L. Bonnafoux, F. Blanco, R. Ballesteros, F. R. Leroux, B. Abarca, F. Colobert, I. Alkorta and J. Elguero, Dalton Trans., 2011, 1387–1395 RSC.
  13. B. Stewart, A. Harriman and L. J. Higham, Organometallics, 2011, 30, 5338–5343 CrossRef CAS.
  14. W. Sun, Q. Zhang, L. Qin, Y. Cheng, Z. Xie, C. Lu and L. Wang, Eur. J. Inorg. Chem., 2010, 4009–4017 CrossRef CAS.
  15. M. A. H. Laramay and J. G. Verkade, Z. Anorg. Allg. Chem., 1991, 605, 163–174 CrossRef CAS.
  16. B. Valeur, Molecular Fluorescence: Principles and Applications, Wiley-VHC Verlag GmbH, Weinheim, 2001 Search PubMed.
  17. HYPERQUAD, P. Gans, A. Sabatini and A. Vacca, Talanta, 1996, 43, 1739 CrossRef.
  18. For selected bibliography on copper sensing see: (a) J. A. Cotruvo Jr., A. T. Aron, K. M. Ramos-Torres and C. J. Chang, Chem. Soc. Rev., 2015 10.1039/c4cs00346b; (b) K. P. Carter, A. M. Young and A. E. Palmer, Chem. Rev., 2014, 114, 4564–4601 CrossRef CAS PubMed; (c) L. M. Hyman and Ka. J. Franz, Coord. Chem. Rev., 2012, 256, 2333–2356 CrossRef CAS PubMed.

Footnote

Electronic supplementary information (ESI) available: General conditions, details of the synthesis, NMR spectroscopic data and fluorescence titrations. CCDC 1031770. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c5ra04386g

This journal is © The Royal Society of Chemistry 2015
Click here to see how this site uses Cookies. View our privacy policy here.